NON INVASIVE MONITORING AFTER AZATHIOPRINE WITHDRAWAL IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN DEEP REMISSION.
There is uncertainty regarding the optimal duration of treatment with azathioprine (AZA) in ulcerative colitis (UC) and Crohn’s disease (CD). We analyzed the clinical course and predictors of relapse after AZA withdrawal in patients in sustained deep remission.A prospective study was performed on patients who stopped their treatment with AZA while being in steroid-free, extended deep remission [=normal clinical, endoscopic and histological indexes, C-reactive protein (CRP) and fecal calprotectin (FC)]. Standard biochemical tests and FC were measured at 3 and 6 months, then every 6 months. Bowel ultrasounds and ileocolonoscopy were performed every 6 and 12 months, respectively. Multivariate analyses for predictors of relapse was performed using a Cox Proportional Hazard Model and Hazard Ratios (HRs) were calculated. Spearman non parametric correlation test was also used. The accuracy of significant predictors was calculated.57 patients with IBD stopped AZA after median 7 years (range 5-19) and were followed up for median 50 months (range 25-85). Twenty-six patients (18/31 UC, 8/26 CD; p=0.003) relapsed, within a median 15 months (range 2-37). FC was the only variable significantly correlated with later relapse of both diseases (UC: HR 3.3, 95%CI 1.2-10; CD: HR 4.5, 95%CI 1.4-12.5). The sensitivity, specificity, positive- and negative-predictive values of FC were 50%, 100%, 100%, 59% in UC and 50%, 94%, 80%, 81% in CD.More than half patients with UC and one third of patients with CD relapse after AZA withdrawal despite previous deep remission. FC positivity is associated with high risk of relapse, allowing early correction of the therapeutic strategy.
View the full article @ Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Authors: Andrea Cassinotti, Alberto Corona, Piergiorgio Duca, Manuela Nebuloni, Giovanni Maconi, Paolo Fociani, Sandro Ardizzone